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Objectives. The purpose of this study was to determine whether
artery responses to acetylcholine are abnormal in
patients with chronic heart failure.
Background . Defective pulmonary artery endotheilum-
dependent responses have been observed In chronic heart failure
models in - , However, pulmonary artery endothelial re.
spouses in h
	
with chronic h failure are unknown .
Meth Twenty-two patlen with chronic treated heart fail-
ure (12 with secondary pulmonary hypertension, Group 1 ; 10 with
no otmry artery pressure, Group II) and 8 control
patients constituted the study groups . Intravascular ultrasound
measurements of pulmonary artery area just beyond the tip of an
8F tension sheath were obtained in response to acetylcholine
(10'6, 10' 5 and 10-4 mol/liter) . The 10'6 mo11liter infusion was
repeated after methylene blue infusion . Indomethacin (S pglmi)
was sequentially added to this combination to 17 patients.
Chronic left-sided congestive heart failure has been shown
pathologically to result in significant intimal hyperpiasia of
the pulmonary vasculature (1). In many of these patients,
significant pulmonary hypertension also develops, whereas
others with a similar degree of left ventricular failure main-
tain normal pulmonary artery pressure, The mechanism for
maintaining normal pulmonary artery pressure in this setting
is unknown. Recent investigations in chronic heart failure
models in animals (2) have shown that pulmonary artery
endothelium-dependent responses may be defective . The
most dramatic consequence of this defective response in
the animal model was enhanced constrictor responses in the
pulmonary circulation. It is unknown, however, whether
humans with chronic heart failure develop abnormal pulmo-
nary artery endothelial responses .
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Results. There were no significant differences among the three
groups in vascular area responses to the lowest concentration
(10-6 and 10-5 molditer) of acetylcholine, but the 10
-4
mol/liter
infusion resulted in significant constriction in Group II patients
(p < 0.05, analysis of variance [ANOVA]) . Pretreatment with
methylene blue in Group II resulted in significant pulmonary
artery vasoconstriction to even the 10 -6 mol/liter acetylcholine
Infusion (10 .4 ± 7.8% in Group H vs. 1 .7 ± 3.9% in the control
group and 0.1 t 4.3% in Group I, p < 0.05, ANOVA) . The
addition of indomethacin resulted in reversal of the constriction In
Group lI patients.
Conclusions. These responses indicate that the pulmonary
artery endothelium may play a significant role in inhibiting
vasoconstriction In patients with chronic heart failure who main •
tain norr.taf pulmonary artery pressure .
(J A Coll Cardiol 1993,22
.1418-24)
High frequency intravascular ultrasound has been vali-
dated as a method of quantifying pulmonary artery area in
vivo in humans (3) . Vessel area obtained with this technique
correlates closely with that obtained using digital angiogra-
phy (4). Therefore, we used this imaging modality to study
pulmonary artery endothelial responses in humans with
chronic heart failure .
Methods
Study patients. Twenty-two patients (12 with chronic
treated congestive heart failure secondary to left ventricular
systolic dysfunction and mean pulmonary artery pressure
>25 mm Hg [Group I] and 10 with clinically similar chronic
treated heart failure and normal pulmonary artery pressures
[Group II]) constituted the study group . The median New
York Heart Association functional class at the time of study
for both Groups I and II was class I!I . There was no
significant difference between Groups I and II in the use of
angiotensin-converting enzyme inhibitors (9 in Groups I and
II), digoxin (8 in Group I, 5 in Group II) or diuretic agents
(12 in Group I, 8 in Group 11) . Four patients in Group I and
two in Group II were receiving calcium channel blocking
agents at the time of study .
Eight age-matched control patients with co oIlai y artery
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disease, normal left ventricular systolic function by single-
plane left ventriculography (mean left ventricular ejection
fraction 59 ± 5%) and normal pulmonary artery pressures at
right heart catheterization constituted the control group . Six
control patients had two-vessel coronary artery disease ; one
had three-vessel disease and one had no significant coronary
artery disease . Medications used by the control patients
included angiotensin-converting enzyme inhibitors for hy-
pertension (five patients), calcium channel blockers (two
patients) and aspirin (three patients) . All nitroglycerin-
containing medications were discontinued for a minimum of
18 h before intravascular study . The study was approved by
the Committee on the Conduct of Human Research at
Virginia Commonwealth University and the Research Com-
mittee of the McGuire Veterans Affairs Medical Center .
Instrumentation . Studies were performed with the pa-
tient resting in the supine position and premedicated with
I to 6 mg of midazolam . Intravascular ultrasound and
Swan-Ganz pressure catheters were placed from the right
femoral vein. A SF or 8F arterial sheath was placed in the
right femoral artery for continuous arterial pressure moni-
toring. A 7F Swan-Ganz catheter was advanced into the
pulmonary artery to obtain mean and phasic pulmonary
artery and capillary wedge pressures as well as thermodilu-
tion cardiac output . Arterial and mixed venous oxygen
saturation were obtained during the experimental protocol in
21 patients .
Intravascular ultrasound imaging was accomplished using
a commercially available ultrasound probe (Sonicath, Bos-
ton Scientific Corporation) . This device is a 6F disposable
catheter that encloses a 20-MHz ultrasound crystal at its tip
and has an optimal axial resolution of 0 .3 mm and optimal
lateral resolution of 0 .5 mm. The catheters were advanced
into the pulmonary artery just beyond the tip of a 7F or 8F
long infusion sheath (Cordis Corporation) using fluoroscopic
guidance. The sheath was then used to deliver incremental
concentrations of acetylcholine according to the methods
outlined in Experimental Protocol . Baseline flow in the
vessel studied was calculated by determining the pulmonary
vascular area obtained with intravascular ultrasound and
multiplying it by the mean velocity obtained with an end-
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Figure 1 . Graphic demonstration of the mean and individual
changes in pulmonary artery (PA) area in response to
10-6,
10-5 and
10' inol/liter of acetylcholine (ACH) . There was significant vaso-
constriction in the heart failure group with normal pulmonary artery
pressure (CHF-NL PA) in response to the 10' mol/liter dose of
acetylcholine . CHF-PUL HTN = heart failure group with second-
ary pulmonary hypertension . *p < 0 .05 (analysis of variance) .
mounted Millar Doppler crystal (3 .5F) (DC-101, Millar In-
struments) . The Doppler crystal was advanced into the same
pulmonary arterial segment as the ultrasound catheter,
through the sheath immediately before placing the ultra-
sound probe . The product of the intravascular ultrasound-
planimetered area and velocity (in cm 3/s) was used to
determine the molar concentrations of acetylcholine to be
infused, as follows :
Qu(mllmin)
'
MALI, - 182g Ach/mol per liter . I min/ml =
grams of acetylcholine to place in 1,000 ml of normal saline
solution at Iml/min,
where 1 .0 ml/min was the infusion rate for all study drugs
;
Qb
= baseline pulmonary artery flow from Doppler and area
measurements ; and
MAch
= molar concentration of acetyl-
choline desired (mol/liter) . The same calculation was used
for the methylene blue infusion (374 g/mol per liter) . The
same vascular region for the entire study was verified by
periodic fluoroscopy (Fig . 1) and by specific vascular ultra-
sound markers (small vascular branches [ :51 mm], vascular
geometry, bright echogenic structures in a specific region of
the vascular wall) that confirmed a stable position of the
catheter. Pulmonary artery plaque in the region being ana-
lyzed was defined as regions of different echo intensity that
appeared to be attached to or part of the intima and that
disrupted the homogeneous echo intensity of the vessel wall
(5) .
Experimental protocol .
Incremental doses of acetylcho-
line
(10-6,
10-5
and 10' mol/liter) were infused in the
pulmonary artery segment for 15-min intervals through the
1420
8F sheath in 10 of 12 Group I patients, 8 of 10 Group 11
patients and 6 of 8 control patients to determine an in vivo
dose-response curve . Continuous real-time intravascular ul-
trasound images of pulmonary artery area throughout the
cardiac cycle just distal to the sheath were recorded on
1/2-in . (1 .3 cm) videotape . Systemic and pulmonary artery
pressures were monitored during each infusion. After these
three doses, the infusion was terminated, and baseline
pulmonary artery area was reestablished . This was followed
by a 3 x 10 -5 mol/liter methylene blue infusion through the
sheath alone and then in combination with 10 -1 mol/liter of
acetylcholine . Methylene blue was used to determine the
effect of inhibition of endothelium-dependent relaxing factor
synthesis on vascular responses to the lowest dose of
acetylcholine (6) . In 17 patients (6 each from Groups I and II
and 5 from the control group), a 5-µg/ml infusion of indo-
methacin was added to the acetylcholine/methylene blue
infusion. Indomethacin was utilized to evaluate what effect
thromboxane and prostazyclin synthesis had on the acetyl-
Mike responses observed after inhibition of endotheliuni-
dependent relaxation. Nitroglycerin (50 to 100 min) was
infused in 14 patients in Groups I and II and 6 control
subjects to assess endothelium-independent relaxation .
anAysis, Pulmonary artery area measurements
for each infusion were the average of three to four consec-
utive cardiac cycles
. Each area measurement was obtained
from an off-line reading station and represented the average
of the smallest and largest areas throughout the cardiac
PORTER ET AL .
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Table 1 .
Baseline Clinical Characteristics of the Three Patient Groups
*p < 0
.05 (analysis of variance [ANOVAJ) . Values presented are mean value ± SD or number. FEV I = forced
expiratory volume at I s ; Group I = chronic heart failure with secondary pulmonary hypertension
; Group 11 =
chronic heart failure with normal pulmonary artery pressure ; IVUS = intravascular ultrasound ; LVEF = left
ventricular ejection fraction ; PCW = pulmonary capillary wedge pressure ; TLC - total lung capacity .
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cycle. Responses to each infusion were compared using
analysis of variance (ANOVA) (Student-Newman-Keuls
multiple comparison procedure) . A p value < 0.05 was
considered significant .
Results
Patient chancterlstics . Table I lists the baseline clinical
and hemodynamic findings in the three groups at the time of
study. The etiology of the cardio^iyopathy was ischernic in
14 patients with heart failure : 7 in Group I and 7 in Group II .
The duration of heart failure symptoms was not different
between Groups I and 11. Pulmonary function tests were
performed in six Group I and seven Group II patients . There
were no differences between Groups I and 11 in forced
expiratory volumes or total lung capacities . However, in the
patients with secondary pulmonary hypertension (Group 1),
pulmonary artery oxygen saturation was significantly lower,
and baseline pulmonary vascular resistance was higher .
Baseline pulmonary artery flow in the vessel segment stud-
ied was not different among the three groups .
Pulmonary artery morphology by intravascular ultra-
sound . Pulmonary artery plaque was identified in 11 (50%)
of 22 arteries in the patients with chronic heart failure . Five
(45%) of the I I arteries with plaque were in patients with
pulmonary hypertension, whereas 6 (55%) were in patients
with normal pulmonary artery pressure . The plaque was
eccentric in 10 of the 11 patients . It was brightly echogenic in
Group I
(n = 12)
Group 11
(n = 10)
Control
Group
(n = 8)
Age (yr)
55±11
56±10 62±5
Heart failure duration (mo)
43 ± 28
42 t 14
Etiology of cardiomyopathy
Ischemic
7 7
Other
5 3
Chest roentgenogram
Pulmonary edema
7/12 0112
Pleural effusion
1112 7112
Cardiomegaly
12/12 8/10
Pulmonary function tests
FEV I M
8!±10 81 10
TLC (liters)
63 t 1 .5 6.1±1 .2
LVEF (%)
20±6 21±6
59±5
PCW (mm HS)
Zi
10±4 6±2
Cardiac output (liters/min) 4 .7 1 .6
4.6 1 .1 4 .7 0.6
Pulmonary vascular resistance (Wood units)
3 .9 1 .7* 1 .8 M 2.0 0.5
Pulmonary artery saturation 54 711
71±4
68±±4
Systemic artery saturation (%) 93±4
97±3 95±2
IVUS vessel diameter (mm)
4.6 ± 0.8 3 .8 0.5 4 .1 0.9
Baseline pulmonary artery flow (mllmin)
16.8 ± 11 .3 15 .3 11 .0 17 .1 12 .2
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Table 2. Percent Change in Pulmonary Artery Area in Response
to Acetylcholine Before and After Administration of
Methylene Blue
*p < 0.05 (ANOVA). Values presented are mean value ± SD . ACH
acetylcholine ; MB = methylene blue ; other abbreviations as in Table 1 .
all cases but did not cause shadowing. In contrast to patients
with heart failure, only two (2
5%) of the eight control
patients had evidence of plaque .
Responses to acetylcholine . Figure I illustrates the
changes in pulmonary arterial area to incremental doses of
acetylcholine . Although none of the three groups exhibited
significant changes in arterial area to 10' or 10' MAN,
of acetylcholine, there was a significant decrease in pul-
monary arterial area in Group 11 patients (chronic heart
failure with normal pulmonary artery pressure) in response
to 10' mol/liter of acetylcholine (1
1 .5 ± 11 .9% decrease vs .
5.2 ± 10.0% decrease in control subjects and 0 .8 ± 4.0%
increase in Group I patients, p < 0.05, ANOVA). Among the
six control patients who received incremental infusions of
acetylcholine, vasoconstriction was elicited in three, and the
other three had no significant area change in response to the
10' mol/liter infusion .
Responses to acetylcholine after methylene blue . Table 2
lists the percent pulmonary artery area responses to meth-
y1ene blue alone and to 10
-6
mol/liter of acetylcholine after
pretreatment with methylene blue . In contrast to
10-6
moll
liter of acetylcholine alone, there was now significant vaso-
constriction in the Group II patients (heart failure and
normal pulmonary artery pressure) (10.4 ± 7.8% area de-
crease in Group II vs . 0.1 ± 4.3% decrease in Group I and
Figure 2. Intravascular ultrasound images of the
pulmonary artery in a patient with chronic heart
failure and normal pulmonary artery pressure . Left,
Response to methylene blue alone . Right, Response
to 10 -1 mol/liter of acetylcholine after pretreatment
with methylene blue. Note the marked constriction
of the pulmonary artery after endothelium-derived
relaxing factor synthesis is inhibited .
PORTER ET Al .
	
1421
EN DOTHIELI t IM-DEPEN DENT RESPONSES IN CHRONIC HEART FAILURE
-25
Effect of MB and Indocin
0
.
.
.
.	
+ m
YOH
I
AYMBW/Ondtoncin
Figure 3. Graphic demonstration of the marked vasoconstriction in
patients with chronic heart failure and normal pulmonary artery
pressure (open squares) to low dose acetylcheline (ACH) after
pretreatment with methylene blue (MB) . After indomethacin (Indo-
cin), there was a significant reversal of the pulmonary artery
constriction in the patients with chronic heart failure who main-
tained normal pulmonary artery pressure . Solid triangles = patients
with chronic heart failure and secondary pulmonary hypertension ;
solid squares - control patients . *p < 0.05 compared with control
and chronic heart fa : ;ure with secondary pulmonary hypertension
(analysis of variance) .
1 .7 ± 3 .9% decrease in control patients, p < 0 .05, ANOVA) .
There was no significant change in pulmonary vascular area
in any of the three groups in response to methylene blue
alone (Table 2) .
Figure 2 is a representative intravascular ultrasound
image of a pulmonary artery in a Group 11 patient with
chronic heart failure and normal pulmonary artery pressure
that illustrates the vasoconstriction that occurred in re-
sponse to acetylcholine only after pretreatment with meth-
ylene blue .
Responses to indomethacin after acetylcholine/methylene
blue infusion . Figure 3 graphically illustrates the change in
pulmonary vascular area in response to acetylcholine, ace-
tylcholine after pretreatment with methylene blue and after a
Percent Change From Baseline
ACH
Alone MB Alone
MB/ACH
Group I
0.5 ± 3.4% 0 .6 3 .7% -0.1 ± 4 .3%
Group 11 1 .1 ± 4 .5% -0.3±5.5%a -10
.4±7.8%®*
Control gfoup 2 .3 ® 9.9% -0 .8 50,1e, -1 .7 ± 3 .9%
1422
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5-µg/ml infusion of indomethacin was added to the 10
-6
mol/liter acetylcholine/methylene blue infusion
. There was
complete reversal of the pulmonary artery constriction seen
with acetylcholine/methylene blue in four of six Group II
patients
. The mean increase in vessel area after indometha-
cin in Group 11 was significantly different from the responses
seen in the other groups (8 .0 ± 7
.6% increase in area in
Group II vs . 3.0 ± 3.4% constriction in Group I and 0
.6 ±
3.9% constriction in the control group
; p < 0.05, ANOVA) .
Of three control patients taking aspirin, two had constriction
and one had dilation in response to indomethacin, whereas
two not taking aspirin either had no change in vessel area or
had constriction . There were no significant changes in local
pulmonary artery pressures (measured from the sheath) in
response to any of the infusions .
Endothelium-Independent pulmonary artery responses . In
14 patients with chronic heart failure (8 with pulmonary
hypertension and 6 with normal pulmonary artery pressure)
and 6 control patients, pulmonary artery responses to nitro-
glycerin were also evaluated . In the patients with chronic
heart failure, five of six with normal pulmonary artery
pressure and six of eight with pulmonary hypertension had
dilation in response to nitroglycerin, indicating the absence
of differential responses to endothelium-independent vasodi-
lators in heart failure with or without pulmonary hyperten-
sion. In contrast, only three of the six control patients had
dilation after nitroglycerin .
Discussion
This study demonstrates that in the pulmonary artery of
humans with chronic heart failure, the response to a local
infusion of acetylcholine depends to a large extent on
whether pulmonary artery pressures remain normal . Patients
with chronic heart failure who maintain normal pulmonary
artery pressure exhibit significant vasoconstriction in re-
sponse to acetylcholine when endothelium-dependent vaso-
dilator responses are blocked by methylene blue. These
findings are consistent with the hypothesis that the pulmo-
nary vascular endotheliumm may play a significant role in
preventing vasoconstriction in chronic heart failure .
We used local infusions of methylene blue to inhibit
pulmonary vasodilator responses to acetylcholine because
of its extensive use in the pulmonary circulation for this
purpose. Hyman et al . (6) demonstrated in the feline pulmo-
nary circulation that methylene blue selectively inhibits
endothelium-dependent vasodilatory responses. Methylene
blue has also been shown to stimulate superoxide anions (8) .
However, its main effects in the pulmonary circulation,
appear to be inhibition of guanylate cyclase (7,9,10) because
it also inhibits pulmonary artery vasodilator responses to
nitroglycerin and bradykinin (10) .
In this study, vasoconstriction in response to acetylcho-
fine in the patients with chronic heart failure with normal
pulmonary artery pressure occurred in two settings . First, it
was seen when acetylcholine was given in the highest
JACC Vol . 22, No. 5
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concentration (10-' mol/liter), Second, it was seen in re-
sponse to lower concentrations of acetylcholine (10 -6 mol/
liter) after pretreatment of the pulmonary vessel segment
with methylene blue . These results suggest that acetylcho-
line was inducing endothelium-mediated vasodilation that
inhibited simultaneous acetylcholine-mediated constriction .
/Endothelium-dependent inhibition of pulmonary vasocon-
striction . Although we observed no difference in response to
the lowest concentration of acetylcholine alone in any of the
three groups, pretreatment of the same vessel with methyl-
ene blue resulted in significant vasoconstriction in the pa-
tients with chronic heart failure who maintained normal
pulmonary artery pressure . This indicates that endothelium-
dependent vasodilatory responses to acetylcholine may be
responsible for inhibiting vasoconstriction to acetylcholine
in th ,'s group. The endothelium in these patients demon-
strates a greater inhibitory role even when compared with
that in the control patients, who had normal left ventricular
systolic function and pulmonary artery pressures . In con-
trast, the patients with chronic heart failure who developed
pulmonary hypertension did not have vasoconstriction in
response to either the 10' molAiter infusion after methylene
blue or to higher concentrations of acetylcholine . Therefore,
acetylcholine does not appear to stimulate endothelium-
dependent vasodHation or even vasoconstriction in the pres-
ence of secondary pulmonary hypertension .
Pulmonary artery constriction in response to acetylcholine .
The vasoconstriction that we observed in response to the
highest dose of acetylcholine
(10-4
mol/liter) in the patients
with chronic heart failure and normal pulmonary artery
pressure was not seen in the patients with secondary pulmo-
nary hypertension or in the control group . The are two
possible reasons for these differences . First, lower rest tone
in the patients with heart failure who maintained normal
pulmonary artery pressure may have influenced the response
to acetylcholine. Hyman and Kadowitz (11) demonstrated in
the feline pulmonary vascular bed that acetylcholine in-
creased lobar artery pressure only when rest tone was low .
Barman et al . (12) observed that higher concentrations of
acetylcholine increased vascular resistance in the pulmonary
artery under rest conditions . These investigators found that
the vasoconstrictor responses were attenuated or reversed
when rest vascular tone was increased . This may explain
why the patients with chronic heart failure with secondary
pulmonary hypertension in our study had no constriction in
response to even the highest concentrations of acetylcho-
line .
Second, acetylcholine may induce enhanced thrombox-
ane synthesis in patients with chronic heart failure and
normal pulmonary artery pressure . In four of the six patients
with heart failure and normal pulmonary artery pressure, the
addition of an indomethacin infusion caused complete rever-
sal of the constriction seen in response to the acetylcholine/
methylene blue infusion . These observations are consistent
with those seen in the pulmonary artery of animal models as
well. Altiere et al . (13) demonstrated that thromboxane
A2
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mediates acetylcholine-induced vasoconstriction in the pul-
monary artery of rabbits. Removal of the pulmonary vascu-
lar endothelium in the rabbits significantly decreased the
vasoconstriction, suggesting that both vasodilator and vaso-
constrictor responses to acetylcholine in the pulmonary
circulation may be endothelium dependent .
High rest thromboxane production has been observed in
humans with secondary pulmonary hypertension (14) . This
high level of thromboxane may also be an important media-
tor of pulmonary artery vasoconstriction in chronic heart
failure . In our study, however, thromboxane-mediatcd va-
soconstriction was seen only in the patients with heart
failure with normal pulmonary artery pressure and only after
inhibition of endothelium-derived relaxing factor with meth-
ylene blue .
Limitations of the study . The observation that acetylcho-
line did not cause direct vasodilation and did not cause
vasoconstriction after endothelium-dependent relaxing fac-
tor synthesis was inhibited in the patients with heart failure
and pulmonary hypertension suggests defective endothelial
function . However, it does not reveal which process oc-
curred first (pulmonary hypertension or abnormal endothe-
lium-dependent responses) . It is possible that the develop-
ment of secondary pulmonary hypertension led to defective
endothelial function. Alterations in endothelial cell function
have occurred in response to isolated increases in pressure
(15). Although pulmonary artery pressure appears to play a
role in predicting the response to acetylcholine, the aug-
mented pulmonary artery constrictor responses to acetyl-
choline in the patients with heart failure who maintain
normal pulmonary artery pressure compared with responses
in our control patients suggest a primary role of the pulmo-
nary vascular endothelium in modulating, tone .
Other factors, such as local pulmonary artery flow rates
and hypoxia, may have influenced the responses we ob-
served (Table 1). Pulmonary artery oxygen saturation, which
may affect endothelial response, was lower in the patients
with secondary pulmonary hypertension . The baseline flow
in the vessel segments studied was not different between the
two heart failure groups . Because we did not assess flow
changes in response to acetylcholine, however, we do not
know whether the different responses that we observed
between the heart failure groups also occur at the microvas-
cular level .
We did not see vasoconstriction in response to the
infusion of methylene blue alone in any of the groups (Table
2). This would be expected in the patients with chronic heart
failure who maintained normal pulmonary artery pressure if
basal levels of endothelium-derived relaxing factor were
increased. It may be that a higher concentration or a longer
duration of methylene blue infusion than the one used in this
study are required to demonstrate this. Kadowitz et al . (16)
reported that pulmonary artery constriction in response to
methylene blue is a dose-dependent phenomenon, and Fine-
man et al. (17) showed that pulmonary artery vasoconstric-
tion in response to methylene blue is time-dependent .
PORTER ET
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Although these findings suggest intact endothelial re-
sponses in patients with chronic heart failure who maintain
normal pulmonary artery pressure, we did not observe a
significant vasodilator response to acetylcholine alone either
in these patients or in the control group. This may be due to
several factors . The control group was slightly older (Table
2) and also had significant atherosclerotic vascular disease .
Both of these factors may cause defective - .endothelial re-
sponses. Second, acetylcholine responses in the pulmonary
artery appear to be tone-dependent (11) . Only three of six
control patients had dilation in response to nitroglycerin, a
finding that suggests that resting vascular tone may have
been different within the control group . Finally, because
vasoconstrictor responses to acetylcholine also appear to be
dose-dependent (16), a lower concentration of acetylcholine
(10-8 or
10-7
mol/liter) may have elicited significant vasodi-
lation in the patients with chronic heart failure with normal
pulmonary artery pressure and in the control group .
Conclusions . Despite these limitations, our findings sup-
port the hypothesis that the pulmonary vascular endothelium
may play a significant role in attenuating vasoconstriction in
the pulmonary artery in chronic treated heart failure . Fur-
ther study of the human pulmonary artery in chronic heart
failure is indicated to define whether intact functional eJo-
thelium prevents secondary pulmonary hypertension from
occurring. Specifically, the physiologic role of basal levels of
endothelium-derived relaxing factor in preventing pulmo-
nary artery constriction in human heart failure needs to be
defined . Using intravascular ultrasound and the infusion
protocol of this study, the basal activity and inhibitory role
of the endothelium can be further delineated in human heart
failure by infusing either specific inhibitors of endothelium-
dependent relaxing factor synthesis or known vasoconstric-
tors that are normally inhibited by the endothelium .
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